Mahdian Nima, Onderková Anna, Brizman Eitan, Pavlíková Gabriela, Vlachopulos Vasilis, Drahoš Milan, Foltán René
Department of Oral & Maxillofacial Surgery, First Faculty of Medicine, Charles University and the General University Hospital, Prague, Czech Republic.
Department of Oral & Maxillofacial Surgery, First Faculty of Medicine, Charles University and the General University Hospital, Prague, Czech Republic.
Br J Oral Maxillofac Surg. 2020 Nov;58(9):e45-e50. doi: 10.1016/j.bjoms.2020.05.031. Epub 2020 Jun 18.
Osteoradionecrosis of the jaw can be treated using both conservative treatment and surgery. External fixation may be used to bridge large resection defects after sequestrectomy for stabilisation and before secondary mandibular reconstruction. We designed a retrospective analysis of 70 patients with osteoradionecrosis treated between the years 2014 and 2018, and found that the use of external fixation greatly improves their outcomes. Patients were grouped according to Notani's classification: those who had Notani I disease were treated surgically but without external fixation; and those with Notani II and Notani III disease were eligible for external fixation. In those with Notani II disease, there was a significant reduction in the number of pathological fractures that occurred with external fixation. In those with Notani III disease, the success rate of primary sequestrectomy was only 1:14; however, those treated with external fixation all successfully healed after their first operation. It was hypothesised that although external fixation would improve outcome, it would come at a detriment to their quality of life (QoL). However, in a subset of these patients, we showed that in addition to increasing successful healing, patients' QoL with the external fixator was no worse than when they had an active osteonecrotic lesion. The treatment of osteoradionecrosis is cumbersome and advanced stages are associated with more complications. The use of an external fixator significantly reduces the probability of pathological fractures and increases the rate of successful healing in patients after mandibular resection. It does this without greatly interfering with patients' lives, while improving their condition sufficiently to allow for subsequent mandibular reconstruction.
颌骨放射性骨坏死可采用保守治疗和手术治疗。在死骨切除术后,可使用外固定来桥接大的切除缺损,以实现稳定,并在二期下颌骨重建之前使用。我们对2014年至2018年间接受治疗的70例颌骨放射性骨坏死患者进行了回顾性分析,发现使用外固定可显著改善其治疗效果。患者根据野谷分类法进行分组:患有野谷I型疾病的患者接受手术治疗,但未使用外固定;而患有野谷II型和野谷III型疾病的患者适合使用外固定。在患有野谷II型疾病的患者中,使用外固定后发生病理性骨折的数量显著减少。在患有野谷III型疾病的患者中,初次死骨切除术的成功率仅为1:14;然而,接受外固定治疗的患者在首次手术后均成功愈合。据推测,尽管外固定会改善治疗效果,但可能会对患者的生活质量(QoL)产生不利影响。然而,在这些患者的一个亚组中,我们表明,外固定除了提高愈合成功率外,患者使用外固定器时的生活质量并不比患有活动性骨坏死病变时更差。颌骨放射性骨坏死的治疗很麻烦,晚期会伴有更多并发症。使用外固定器可显著降低病理性骨折的概率,并提高下颌骨切除术后患者的愈合成功率。它在不大幅干扰患者生活的情况下做到了这一点,同时充分改善了他们的病情,以便进行后续的下颌骨重建。